TNFSF10 and non-small cell lung carcinoma: In addition, enhancement of TRAIL sensitivity in AXL-positive NSCLC cells was obtained with the use of the GL21.T-miR-212 chimera thanks to the ability of miR-212 to downregulate PED protein expression, a major player in TRAIL resistance in NSCLC [50,51,52].